Compare EVT & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVT | BLFS |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 2003 | 2013 |
| Metric | EVT | BLFS |
|---|---|---|
| Price | $28.16 | $38.61 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $31.29 |
| AVG Volume (30 Days) | 86.3K | ★ 1.0M |
| Earning Date | 01-01-0001 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.94 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | N/A | $19.76 |
| Revenue Next Year | N/A | $17.03 |
| P/E Ratio | ★ N/A | $41.07 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $23.00 | $17.86 |
| 52 Week High | $29.65 | $39.76 |
| Indicator | EVT | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 49.24 | 59.99 |
| Support Level | $27.59 | $34.38 |
| Resistance Level | $29.45 | $39.76 |
| Average True Range (ATR) | 0.43 | 1.07 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 63.16 | 70.05 |
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.